Kaletra
Product Images NDC 0074-6799

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Kaletra (NDC 0074-6799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Kaletra Tablets And Oral Solution Spl 01

An illustration showing a formula for calculating body surface area (BSA) in square meters using height in centimeters and weight in kilograms, with a specific divisor of 3600 under the square root.*

FDA Label Image

Kaletra Tablets And Oral Solution Spl 02

Chemical structure diagram of the active ingredient in Kaletra, showing the molecular arrangement of atoms and bonds in the compound.*

FDA Label Image

Kaletra Tablets And Oral Solution Spl 03

Chemical structure of the active ingredient in Kaletra, illustrating the molecular arrangement with labeled atoms and bonds of the compound.*

FDA Label Image

Kaletra Tablets And Oral Solution Spl 04

Kaletra tablet label showing the strengths 200 mg/50 mg of Lopinavir and Ritonavir. The label includes a warning alert about medicines that should not be taken with Kaletra, instructions for pharmacists, and storage conditions. It notes the package contains 120 tablets and is labeled by AbbVie Inc.*

FDA Label Image

Kaletra Tablets And Oral Solution Spl 05

Kaletra 200 mg / 50 mg tablets label displaying active ingredients lopinavir and ritonavir. Container holds 120 tablets. Label includes warnings about drug interactions with Kaletra and pharmacist instructions. Storage and dispensing directions are provided. Manufactured by AbbVie Inc.*

FDA Label Image

Kaletra Tablets And Oral Solution Spl 06

Kaletra tablets label featuring the active ingredients Lopinavir and Ritonavir with a strength of 100 mg/25 mg per tablet. The label shows the package contains 60 tablets and specifies storage instructions between 20°C to 25°C. It includes patient and pharmacist warnings, the AbbVie Inc. labeler, and packaging details with barcodes and lot information placeholders.*

FDA Label Image

Kaletra Tablets And Oral Solution Spl 07

Kaletra 100 mg / 25 mg tablets packaging label showing the proprietary name, active ingredients (Lopinavir and Ritonavir), and strength. The label includes a 60-tablet count, manufacturer AbbVie Inc., and a highlighted alert advising to find out about medicines that should not be taken with Kaletra. Additional storage and dispensing instructions are visible.*

FDA Label Image

Kaletra Tablets And Oral Solution Spl 08

Kaletra oral solution 80 mg/20 mg per mL carton, 160 mL, labeled with active ingredients lopinavir and ritonavir. The label includes handling instructions, storage conditions (2-8°C until dispensed), and warnings about medicine interactions. Manufactured by AbbVie Inc., the packaging specifies product details, a barcode, and pharmacy dispensing guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.